Estadísticas de AR-V7 as a biomarker for resistance to treatment with abiraterone/enzalutamide in three Latin American countries: a hypothetical cost-saving analysis

Visitas totales

views
AR-V7 as a biomarker for resistance to treatment with abiraterone/enzalutamide in three Latin American countries: a hypothetical cost-saving analysis 0

Visitas totales por mes

views
enero 2024 0
febrero 2024 0
marzo 2024 0
abril 2024 0
mayo 2024 0
junio 2024 0
julio 2024 0

Visitas de archivo

views
Rafael Adrián Pacheco-Orozco, Lorena Montealegre-Páez_2020.pdf 11